Takeda Pharmaceutical Co Ltd (NYSE: TAK) has signed up for a gene therapy pact, encoding a $2 billion biobucks deal with Code ...
https://www.google.com/url?rct=j&sa=t&url=https://www.benzinga.com/general/biotech/22/02/25758137/takeda-inks-2b-gene-therapy-pact-with-code-biotherapeutics&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGrhRrvZANU_zl7eZ7Cjw78DE3ZZw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.